IP Library Patent Application 17916219
Patent Application
App. No. 17/916,219

TISSUE INTERFACE FOR NEGATIVE PRESSURE AND INSTILLATION THERAPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/916,219
Abstract

Dressings, systems, methods for treating a tissue site, and methods for manufacturing a dressing are described. A dressing material can be provided. The dressing material can be felted to a first felting level, and localized portions of the dressing material can be felted to a second level. The localized portions can be a plurality of debridement cavities disposed in a contact surface. A tissue interface can have a first side, a second side, and a first thickness from the first side to the second side. A plurality of blind apertures an be disposed in the first side, each of the blind apertures having a second thickness from the first side to the second side. The tissue interface can have a first density at the first thickness and a second density at the second thickness.

Claims (61)

1 . A method of manufacturing a dressing for treating a tissue site, the method comprising:

providing a dressing material;

felting the dressing material to a first felting level; and

felting localized portions of the dressing material to a second felting level to form a plurality of debridement cavities disposed in a contact surface.

2 . The method of claim 1 , wherein felting the dressing material to a first felting level comprises increasing a density of the dressing material.

3 . The method of claim 2 , wherein the density of the dressing material increases by a factor of three.

4 . The method of claim 1 , wherein felting localized portions of the dressing material to a second felting level comprises increasing a density of the dressing material at the plurality of debridement cavities.

5 . The method of claim 4 , wherein the density of the debridement cavities is five times greater than an original density of the dressing material.

6 . The method of claim 1 , wherein felting localized portions of the dressing material to a second felting level comprises applying a mandrel tool to the contact surface of the dressing material.

7 . The method of claim 6 , wherein the mandrel tool has a plurality of projections.

8 . The method of claim 7 , wherein the method further comprises heating the plurality of projections.

9 . The method of claim 1 , wherein felting the dressing material to a first felting level comprises compressing the dressing material from a thickness of about 30 mm to a thickness of about 10 mm.

10 . The method of claim 9 , wherein felting localized portions of the dressing material to a second felting level comprises compressing the localized portions of the dressing material from the thickness of about 10 mm to a thickness of about 2 mm to about 5 mm.

11 . The method of claim 1 , wherein felting localized portions of the dressing material to a second felting level comprises forming transition zones between the debridement cavities and the contact surface.

12 . The method of claim 11 , wherein the transition zones comprise large radii.

13 . The method of claim 1 , wherein felting localized portions of the dressing material to a second felting level comprises forming a plurality of voids.

14 . The method of claim 13 , wherein the forming the plurality of voids comprises forming a plurality of circular voids.

15 . The method of claim 1 , wherein providing the dressing material comprises providing an open-cell reticulated foam.

16 . A dressing for treating a tissue site, the dressing comprising a tissue interface having:

a first side, a second side, and a first thickness from the first side to the second side;

a plurality of blind apertures disposed in the first side, each of the blind apertures having a second thickness from the first side to the second side; and

the tissue interface having a first density at the first thickness and a second density at the second thickness.

17 . The dressing of claim 16 , wherein the second density is greater than the first density.

18 . The dressing of claim 16 , wherein the second density is five times greater than the first density.

19 . The dressing of claim 16 , wherein the second thickness is less than the first thickness.

20 . The dressing of claim 16 , wherein the first thickness is about 10 mm.

21 . The dressing of claim 16 , wherein the second thickness is between about 2 mm and about 4 mm.

22 . The dressing of claim 16 , further comprising transition zones between the first thickness and the second thickness.

23 . The dressing of claim 22 , wherein the transition zones comprise large radii.

24 . The dressing of claim 16 , wherein the tissue interface comprises an open-cell reticulated foam.

25 . A system for providing negative-pressure therapy to a tissue site, the system comprising:

a tissue interface having a first density at a first thickness and a second density at a second thickness, the tissue interface configured to be positioned adjacent to the tissue site;

a sealing member configured to be disposed over the tissue interface to create a sealed space; and

a negative-pressure source configure to be fluidly coupled to the sealed space.

26 . The system of claim 25 , wherein the second density is greater than the first density.

27 . The system of claim 25 , wherein the second density is five times greater than the first density.

28 . The system of claim 25 , wherein the second thickness is less than the first thickness.

29 . The system of claim 25 , wherein the first thickness is about 10 mm.

30 . The system of claim 25 , wherein the second thickness is between about 2 mm and about 4 mm.

31 . The system of claim 25 , further comprising transition zones between the first thickness and the second thickness.

32 . The system of claim 31 , wherein the transition zones comprise large radii.

33 . The system of claim 25 , wherein the tissue interface comprises an open-cell reticulated foam.

34 . A tissue interface for treating a tissue site, the tissue interface formed by a process comprising:

providing a dressing material;

felting the dressing material to a first felting level; and

felting localized portions of the dressing material to a second felting level to form a plurality of debridement cavities disposed in a contact surface.

35 . The tissue interface of claim 34 , wherein felting the dressing material to a first felting level comprises increasing a density of the dressing material.

36 . The tissue interface of claim 35 , wherein the density of the dressing material increases by a factor of three.

37 . The tissue interface of claim 34 , wherein felting localized portions of the dressing material to a second felting level comprises increasing a density of the dressing material at the plurality of debridement cavities.

38 . The tissue interface of claim 37 , wherein the density of the debridement cavities is five times greater than an original density of the dressing material.

39 . The tissue interface of claim 34 , wherein felting localized portions of the dressing material to a second felting level comprises applying a mandrel tool to the contact surface of the dressing material.

40 . The tissue interface of claim 39 , wherein the mandrel tool has a plurality of projections.

41 . The tissue interface of claim 40 , wherein the process further comprises heating the plurality of projections.

42 . The tissue interface of claim 34 , wherein felting the dressing material to a first felting level comprises compressing the dressing material from a thickness of about 30 mm to a thickness of about 10 mm.

43 . The tissue interface of claim 42 , wherein felting localized portions of the dressing material to a second felting level comprises compressing the localized portions of the dressing material from the thickness of about 10 mm to a thickness of about 2 mm to about 5 mm.

44 . The tissue interface of claim 34 , wherein felting localized portions of the dressing material to a second felting level comprises forming transition zones between the debridement cavities and the contact surface.

45 . The tissue interface of claim 44 , wherein the transition zones comprise large radii.

46 . The tissue interface of claim 34 , wherein felting localized portions of the dressing material to a second felting level comprises forming a plurality of voids.

47 . The tissue interface of claim 46 , wherein the forming the plurality of voids comprises forming a plurality of circular voids.

48 . The tissue interface of claim 34 , wherein providing the dressing material comprises providing an open-cell reticulated foam.

49 . The systems, methods, and apparatuses as described and illustrated herein.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2024
From: KCI LICENSING, INC.
To: KCI MANUFACTURING UNLIMITED COMPANY
Reel/Frame 066064/0923 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION LISTED ON SCHEDULE OF IP RIGHTS ATTACHED TO ASSIGNMENT AT LINES 55: 71; 89; 116-129; AND 131 NEED TO BE DELETED PREVIOUSLY RECORDED AT REEL: 064788 FRAME: 0823. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 13, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064886/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064788/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2023
From: LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 064449/0982 →